| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/04/2009 | WO2009033734A3 Use of a peptide as a therapeutic agent |
| 06/04/2009 | WO2009033657A3 Use of trp6-triptorelin and d-leu6-leuprolide as therapeutic agents |
| 06/04/2009 | WO2009027753A4 Composition and method inhibiting inflammation |
| 06/04/2009 | WO2008139262A3 Oligoribonucleotides and uses thereof |
| 06/04/2009 | WO2001060458A3 Inhibitors of prenyl-protein transferase |
| 06/04/2009 | US20090143724 Microprojection Array Immunization Patch and Method |
| 06/04/2009 | US20090143568 Recombinant gelatins |
| 06/04/2009 | US20090143479 Pharmaceutical compositions comprising terbinafine |
| 06/04/2009 | US20090143470 Invisible Antimicrobial Glove and Hand Antiseptic |
| 06/04/2009 | US20090143438 Novel Pyridine Derivative Having Anti-Helicobacter Pylori Activity |
| 06/04/2009 | US20090143427 4-Oxoquinoline derivatives |
| 06/04/2009 | US20090143400 Purine derivatives having immuno-modulating properties |
| 06/04/2009 | US20090143373 Quinolone carboxylic acid-substituted rifamycin derivatives |
| 06/04/2009 | US20090143370 Non-nucleoside Reverse Transcriptase Inhibitors |
| 06/04/2009 | US20090143365 Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors |
| 06/04/2009 | US20090143353 Antifungal bicyclic hetero ring compounds |
| 06/04/2009 | US20090143314 Compositions and methods for combination antiviral therapy |
| 06/04/2009 | US20090143313 Treatment or Prevention of Hemorrhagic Viral Infections with Immunomodulator Compounds |
| 06/04/2009 | US20090143312 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 06/04/2009 | US20090143308 Yeast membrane protein expression system and its application in drug screening |
| 06/04/2009 | US20090143299 Novel antimicrobial peptides and use thereof |
| 06/04/2009 | US20090142841 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 06/04/2009 | US20090142782 Using actinobacillus specific immunogolbulins to diagnose gum disease |
| 06/04/2009 | US20090142431 Algal and algal extract dietary supplement composition |
| 06/04/2009 | US20090142429 Silicibacter sp. strain useful for genetic transformation of marine algae and production of antibiotic agents |
| 06/04/2009 | US20090142423 Use of extracts or extractants of the guajacum types, said extracts or extractants bringing about phosphodiesterase-4 inhibition and method for producing the same |
| 06/04/2009 | US20090142418 Antiviral composition comprising alnus japonica extracts |
| 06/04/2009 | US20090142376 Chlamydia polypeptides and corresponding dna fragments and uses thereof |
| 06/04/2009 | US20090142375 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses madiated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
| 06/04/2009 | US20090142373 Immunizing Against HIV Infection |
| 06/04/2009 | US20090142353 Human Tumor Necrosis Factor Receptor TR17 |
| 06/04/2009 | US20090142339 Humanized Anti-CCR2 Antibodies and Methods of Use Therefor |
| 06/04/2009 | US20090142329 Interleukin-1 Beta Converting Enzyme Like Apoptosis Protease-3 and 4 |
| 06/04/2009 | US20090142327 Novel Class of Therapeutic Protein Based Molecules |
| 06/04/2009 | US20090142314 Maternal supplement |
| 06/04/2009 | US20090142313 Vaginal delivery system |
| 06/04/2009 | US20090142299 Macrocyclic tetrazolyl hepatitis c serine protease inhibitors |
| 06/04/2009 | CA2853152A1 Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms |
| 06/04/2009 | CA2706929A1 Novel naphthyridine derivative monohydrate and method for producing the same |
| 06/04/2009 | CA2706656A1 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
| 06/04/2009 | CA2706432A1 Antiviral nucleoside compounds |
| 06/03/2009 | EP2065468A1 Modifications of hiv env enhance immunogenicity for genetic immunization |
| 06/03/2009 | EP2065379A1 Benzimidazole compound having gastric acid secretion inhibitory activity |
| 06/03/2009 | EP2065377A1 Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same |
| 06/03/2009 | EP2065053A1 Cell death inhibitor |
| 06/03/2009 | EP2065049A1 The use of solidago virgaurea in the preparation of a medicament for treatment and prevention of a virus |
| 06/03/2009 | EP2065040A2 Sphingolipids against pathological processes in lipid rafts |
| 06/03/2009 | EP2064209A1 Pyrrole derivatives with antibacterial activity |
| 06/03/2009 | EP2064207A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 06/03/2009 | EP2064194A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 06/03/2009 | EP2064181A1 4, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 06/03/2009 | EP2064180A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 06/03/2009 | EP2063962A2 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| 06/03/2009 | EP2063883A2 Binding interaction of proanthocyanidins with bacteria and bacterial components |
| 06/03/2009 | EP2063882A2 Tyrosine kinase inhibitors for prevention or treatment of infection |
| 06/03/2009 | EP1814860B1 Substituted 5-carboxyamide pyrazoles and [1,2,4]triazoles as antiviral agents |
| 06/03/2009 | EP1648431B1 Novel use of a polyamine-poor composition for the production of a medical human food |
| 06/03/2009 | EP1218544B1 TAR RNA binding peptides |
| 06/03/2009 | EP1111054B1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them |
| 06/03/2009 | EP0772677B1 T cell activation |
| 06/03/2009 | CN101448551A Use of chalcones for the treatment of viral disorders |
| 06/03/2009 | CN101445555A Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 06/03/2009 | CN101445504A Dioxane-2-alkyl carbamates derivatives |
| 06/03/2009 | CN101445493A Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors |
| 06/03/2009 | CN101444509A Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 06/03/2009 | CN100494388C Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 06/03/2009 | CN100494380C A nucleodite sequence of anti-hepatitis virus C infection and preventing and curing hepatitis virus C and its fragment and application |
| 06/03/2009 | CN100494182C Regulatory factor of tumor necrosis alpha factor |
| 06/03/2009 | CN100493618C Series non-virus vector, and medicinal composition containing same |
| 06/03/2009 | CN100493616C Polyepitope and composite polyepitope DNA vaccine of HIV |
| 06/03/2009 | CN100493605C Use of human lysozyme in preparing anti-virus medicines for influenza |
| 06/03/2009 | CN100493547C Decoction for treating tuberculosis |
| 06/03/2009 | CN100493521C Medicine for treating venereal disease and production method |
| 06/03/2009 | CN100493513C Application of 4-de-dimethyltetracycline derivative |
| 06/03/2009 | CN100493495C Novel schisandra fruit soft capsule formulation and its preparation method |
| 06/03/2009 | CN100493494C American ginseng oral disintegration tablet and its preparing process |
| 06/02/2009 | US7541446 Transcriptional activator fusion proteins which comprises both tetracycline controlled transactivator proteins and reverse tetracycline transactivator proteins |
| 06/02/2009 | US7541381 Sulfur compounds such as 3-((4-chloroanilino)sulfonyl)thio-phene-2-carboxylic acid, used as enzymes inhibitors for prophylaxis of antibiotic resistant bacterial infections |
| 06/02/2009 | US7541378 tert-butyl 3-amino-1H-thieno[2,3-c]pyrazole-5-carboxylate; N-benzyl-3-[(4-fluorobenzoyl)amino]-1H-thieno[2,3-c]pyrazole-5-carboxamide; treats a disease caused associated with an altered (disregulated) protein kinase activity e.g cancer, cell proliferative disorders, Alzheimer's disease, viral infections |
| 06/02/2009 | US7541375 Azole derivatives and pharmaceutical compositions containing them |
| 06/02/2009 | US7541369 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2009 | US7541362 7-(3,4-Dichlorophenyl)-4,7-dihydro-5-methyl-6-(5-phenyl-2-oxazolyl)pyrazolo[1, 5-a]pyrimidine |
| 06/02/2009 | US7541354 Bicyclo-pyrazoles |
| 06/02/2009 | US7541353 Enzyme inhibitors; interferons; interleukins; cyclosporins |
| 06/02/2009 | US7541352 Compounds for the treatment of hepatitis C |
| 06/02/2009 | US7541351 Compounds for the treatment of hepatitis C |
| 06/02/2009 | US7541334 Hybrid peptides modulate the immune response |
| 06/02/2009 | US7541332 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity |
| 06/02/2009 | US7541139 Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins |
| 06/02/2009 | US7541042 Topical compositions containing Bacillus coagulans extracellular products and uses thereof |
| 06/02/2009 | US7541036 Human immunodeficiency virus type 1 (HIV-1) matrix (MA or p17) polypeptide capable of inducing anti-p17 antibodies that neutralize the proinflammatory activities of the MA protein |
| 06/02/2009 | US7541032 Antigen uptake receptor for Candida albicans on dendritic cells |
| 06/02/2009 | US7541031 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα |
| 06/02/2009 | US7541029 Anti-rhesus D monoclonal antibodies |
| 06/02/2009 | CA2526954C Antibiotics containing bone substitute material with sustained active substance release |
| 06/02/2009 | CA2512475C Compositions and methods for combination antiviral therapy |
| 06/02/2009 | CA2450868C Non-nucleoside reverse transcriptase inhibitors |
| 06/02/2009 | CA2425395C Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 06/02/2009 | CA2380455C 9a-azalides with antibacterial activity |
| 06/02/2009 | CA2371728C High dose radionuclide complexes for bone marrow suppression |